Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals metabolic parameters enhance treatment response evaluation in Hodgkin lymphoma, suggesting improved clinical outcomes.
Baseline volumetric parameters and long-interval metabolic changes are powerful prognostic markers in Hodgkin Lymphoma. ΔSUVmax₁₋₃ provides additional risk stratification beyond baseline measurements, supporting integration of dynamic PET metrics into clinical practice.
No takes yet. Share an insight, caveat, or question.
Uysal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: